1. Home
  2. Companies
  3. Halozyme Therapeutics
  4. Financial Ratios
  5. DSO Ratio
Halozyme Therapeutics logo
Halozyme Therapeutics HALO
$ 63.08 -2.19%

Annual report 2025
added 02-17-2026

report update icon

Halozyme Therapeutics DSO Ratio 2011-2026 | HALO

Annual DSO Ratio Halozyme Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
93.4 93.7 51.3 - 40.2 107 111 72.1 25.5 39 87.6 44.3 60.6 135 14.7

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
135 14.7 69.7

Quarterly DSO Ratio Halozyme Therapeutics

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
84.8 86.7 102 - 76 78 97.5 - 92 86 107 - 92.3 90.8 79.7 - 104 80.8 95.4 73.3 137 161 283 101 117 139 71.7 45.5 107 77.8 77 10.7 31.7 59.8 58.4 36.7 44.9 42.9 51.6 75.8 142 68.2 102 27.5 57.2 45.4 69.6 66.4 51.8 57.4 95.6 65.8 269 185 110 85.6 9 8.9 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
283 8.9 86.5

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
Advaxis Advaxis
ADXS
 		88.1 - -9.65 % $ 45.9 M usaUSA
I-Mab I-Mab
IMAB
 		271 - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		216 - - $ 1.01 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		204 - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		84.7 - - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
 		20.6 $ 0.88 -2.05 % $ 6.47 M chinaChina
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
 		37.5 $ 22.46 0.72 % $ 3.72 B usaUSA
Aptinyx Aptinyx
APTX
 		46.9 - -39.0 % $ 4.57 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		2.75 K - -1.52 % $ 24.7 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		61.7 - - $ 7.46 M israelIsrael
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		115 - -4.8 % $ 255 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		17.9 - 1.93 % $ 17.4 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
 		52.4 - -3.03 % $ 260 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
 		87.4 - - $ 35.4 M usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
 		24.7 - -0.88 % $ 598 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
 		186 - -10.17 % $ 12.2 K usaUSA
Aravive Aravive
ARAV
 		16.8 - -13.39 % $ 1.45 M usaUSA
Genmab A/S Genmab A/S
GMAB
 		97.9 $ 26.78 0.53 % $ 16.8 B danmarkDanmark
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
 		59 - 17.91 % $ 11.1 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
 		6.83 - - $ 169 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		0.114 - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
 		103 $ 4.08 -0.61 % $ 436 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		106 $ 23.06 -1.54 % $ 2.93 B usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
 		198 $ 1.22 2.1 % $ 203 M usaUSA
ImmuCell Corporation ImmuCell Corporation
ICCC
 		47.5 $ 8.34 1.07 % $ 75.3 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		58.2 $ 1.49 4.58 % $ 397 M britainBritain
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		28.1 $ 2.92 -0.14 % $ 4.81 M israelIsrael
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
 		2.47 - - $ 546 M usaUSA